BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34170085)

  • 1. Increased gene expression of TIMP1 and CHI3L1 in fine-needle aspiration biopsy samples from papillary thyroid cancer as compared to benign nodules.
    Dimitrova I; Shinkov A; Dodova R; Ivanova R; Kirilov G; Kyurkchiyan S; Kaneva R; Kovatcheva R
    Diagn Cytopathol; 2021 Sep; 49(9):1045-1051. PubMed ID: 34170085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression Levels of miR-30a-5p in Papillary Thyroid Carcinoma: A Comparison Between Serum and Fine Needle Aspiration Biopsy Samples.
    Igci YZ; Ozkaya M; Korkmaz H; Bozgeyik E; Bayraktar R; Ulasli M; Erkilic S; Eraydin A; Oztuzcu S
    Genet Test Mol Biomarkers; 2015 Aug; 19(8):418-23. PubMed ID: 26047355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bethesda classification is a valuable guide for fine needle aspiration reports and highly predictive especially for diagnosing aggressive variants of papillary thyroid carcinoma.
    Evranos B; Polat SB; Baser H; Ozdemir D; Kilicarslan A; Yalcin A; Ersoy R; Cakir B
    Cytopathology; 2017 Aug; 28(4):259-267. PubMed ID: 27666595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the PIK3CA gene expression level in FNAB washouts equivalent to that in postoperative tissue specimens of papillary thyroid carcinoma?
    Wojciechowska-Durczynska K; Krawczyk-Rusiecka K; Cyniak-Magierska A; Zygmunt A; Dedecjus M; Lewinski A
    Neuro Endocrinol Lett; 2011; 32(1):59-63. PubMed ID: 21407159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum biomarkers of papillary thyroid cancer.
    Makki FM; Taylor SM; Shahnavaz A; Leslie A; Gallant J; Douglas S; Teh E; Trites J; Bullock M; Inglis K; Pinto DM; Hart RD
    J Otolaryngol Head Neck Surg; 2013 Feb; 42(1):16. PubMed ID: 23663694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of KDM1A suppresses tumour migration and invasion by epigenetically regulating the TIMP1/MMP9 pathway in papillary thyroid cancer.
    Zhang W; Sun W; Qin Y; Wu C; He L; Zhang T; Shao L; Zhang H; Zhang P
    J Cell Mol Med; 2019 Aug; 23(8):4933-4944. PubMed ID: 31211500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of BRAF V600E Mutation and Cytomorphological Features for the Optimization of Papillary Thyroid Cancer Diagnostics in Cytologically Indeterminate Thyroid Nodules.
    Beiša A; Kvietkauskas M; Beiša V; Stoškus M; Ostanevičiūtė E; Jasiūnas E; Griškevičius L; Šeinin D; Šileikytė A; Strupas K
    Exp Clin Endocrinol Diabetes; 2019 Apr; 127(4):247-254. PubMed ID: 29566402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FNAB of benign thyroid nodules with papillary hyperplasia: a cytological and histological evaluation.
    Pusztaszeri MP; Krane JF; Cibas ES; Daniels G; Faquin WC
    Cancer Cytopathol; 2014 Sep; 122(9):666-77. PubMed ID: 24891128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of ultrasound in thyroid nodules with a cytology reading of "suspicious for papillary thyroid carcinoma".
    Kwak JY; Kim EK; Kim MJ; Hong SW; Choi SH; Son EJ; Oh KK; Park CS; Chung WY; Kim KW
    Thyroid; 2008 May; 18(5):517-22. PubMed ID: 18407756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of BRAF V600E mutation detection of fine-needle aspiration biopsy on diagnosis and treatment guidance of papillary thyroid carcinoma.
    Qi W; Shi C; Zhang P; Feng L; Wang J; Chen D
    Pathol Res Pract; 2020 Aug; 216(8):153037. PubMed ID: 32703500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction Table and Nomogram as Tools for Diagnosis of Papillary Thyroid Carcinoma: Combined Analysis of Ultrasonography, Fine-Needle Aspiration Biopsy, and BRAF V600E Mutation.
    Kim SK; Lee JH; Woo JW; Park I; Choe JH; Kim JH; Kim JS
    Medicine (Baltimore); 2015 May; 94(21):e760. PubMed ID: 26020381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of shear wave elastography to detect papillary thyroid carcinoma in thyroid nodules: efficacy of the standard deviation elasticity.
    Kim HJ; Kwak MK; Choi IH; Jin SY; Park HK; Byun DW; Suh K; Yoo MH
    Korean J Intern Med; 2019 Jul; 34(4):850-857. PubMed ID: 29466846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGF-C Is a Thyroid Marker of Malignancy Superior to VEGF-A in the Differential Diagnostics of Thyroid Lesions.
    Woliński K; Stangierski A; Szczepanek-Parulska E; Gurgul E; Budny B; Wrotkowska E; Biczysko M; Ruchala M
    PLoS One; 2016; 11(2):e0150124. PubMed ID: 26900960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph node fine-needle aspiration washout thyroglobulin in papillary thyroid cancer: Diagnostic value and the effect of thyroglobulin antibodies.
    Konca Degertekin C; Yalcin MM; Cerit T; Ozkan C; Kalan I; Iyidir OT; Altinova AE; Akturk M; Toruner F; Akin M; Cakir N
    Endocr Res; 2016 Nov; 41(4):281-289. PubMed ID: 26905960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRAF V600E mutation and microRNAs are helpful in distinguishing papillary thyroid malignant lesions: Tissues and fine needle aspiration cytology cases.
    Zarkesh M; Zadeh-Vakili A; Akbarzadeh M; Nozhat Z; Fanaei SA; Hedayati M; Azizi F
    Life Sci; 2019 Apr; 223():166-173. PubMed ID: 30890403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of false-negative papillary thyroid carcinomas by the routine analysis of BRAF(T1799A) mutation on fine-needle aspiration biopsy specimens: a prospective study of 814 thyroid FNAB patients.
    Cañadas-Garre M; Becerra-Massare P; López de la Torre-Casares M; Villar-del Moral J; Céspedes-Mas S; Vílchez-Joya R; Muros-de Fuentes T; García-Calvente C; Piédrola-Maroto G; López-Nevot MA; Montes-Ramírez R; Llamas-Elvira JM
    Ann Surg; 2012 May; 255(5):986-92. PubMed ID: 22504197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-accuracy Detection of Preoperative Thyroid Nodules Using Combination of BRAF
    Zhang Y; Zhang Z; Ma J; Pu J; Hou P; Yang Q
    Arch Med Res; 2018 Aug; 49(6):365-372. PubMed ID: 30518486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TIMP1 and SERPIN-A overexpression and TFF3 and CRABP1 underexpression as biomarkers for papillary thyroid carcinoma.
    Hawthorn L; Stein L; Varma R; Wiseman S; Loree T; Tan D
    Head Neck; 2004 Dec; 26(12):1069-83. PubMed ID: 15515157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The combined role of ultrasound and frozen section in surgical management of thyroid nodules read as suspicious for papillary thyroid carcinoma on fine needle aspiration biopsy: a retrospective study.
    Moon HJ; Kwak JY; Kim EK; Kim MJ; Park CS; Chung WY; Son EJ
    World J Surg; 2009 May; 33(5):950-7. PubMed ID: 19288281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of BRAF mutation detection in fine-needle aspiration biopsy samples read as "suspicious for papillary thyroid carcinoma".
    Jara SM; Bhatnagar R; Guan H; Gocke CD; Ali SZ; Tufano RP
    Head Neck; 2015 Dec; 37(12):1788-93. PubMed ID: 24989827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.